David Ambrož

2.1k total citations
40 papers, 300 citations indexed

About

David Ambrož is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, David Ambrož has authored 40 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 23 papers in Cardiology and Cardiovascular Medicine and 6 papers in Genetics. Recurrent topics in David Ambrož's work include Pulmonary Hypertension Research and Treatments (35 papers), Cardiovascular Issues in Pregnancy (10 papers) and Cardiac Arrhythmias and Treatments (6 papers). David Ambrož is often cited by papers focused on Pulmonary Hypertension Research and Treatments (35 papers), Cardiovascular Issues in Pregnancy (10 papers) and Cardiac Arrhythmias and Treatments (6 papers). David Ambrož collaborates with scholars based in Czechia, Switzerland and Slovakia. David Ambrož's co-authors include Pavel Jansa, Aleš Linhart, Michael Aschermann, Jaroslav Lindner, Eckhard Mayer, Søren Mellemkjær, Iréne Lang, Adam Torbicki, Štěpán Havránek and Isabel Blanco and has published in prestigious journals such as PLoS ONE, Thrombosis and Haemostasis and European Radiology.

In The Last Decade

David Ambrož

36 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Ambrož Czechia 10 254 198 62 60 23 40 300
Doug Helmersen Canada 10 165 0.6× 129 0.7× 49 0.8× 35 0.6× 41 1.8× 18 247
Katsumasa Miyaji Japan 10 349 1.4× 261 1.3× 65 1.0× 108 1.8× 62 2.7× 22 390
Marcin Waligóra Poland 10 252 1.0× 211 1.1× 43 0.7× 27 0.5× 22 1.0× 49 332
Jaroslaw Dudczak Austria 2 249 1.0× 161 0.8× 139 2.2× 81 1.4× 18 0.8× 2 276
J. Deague Australia 6 252 1.0× 202 1.0× 16 0.3× 32 0.5× 33 1.4× 10 344
F. Leroy Ladurie France 3 303 1.2× 210 1.1× 97 1.6× 88 1.5× 30 1.3× 5 336
J Suntharalingam United Kingdom 7 257 1.0× 141 0.7× 79 1.3× 77 1.3× 23 1.0× 16 281
S Cabrol France 5 310 1.2× 227 1.1× 28 0.5× 96 1.6× 24 1.0× 8 339
Panagiota Xanthouli Germany 10 231 0.9× 129 0.7× 33 0.5× 34 0.6× 16 0.7× 34 274
Hiroto Shimokawahara Japan 8 317 1.2× 281 1.4× 100 1.6× 82 1.4× 24 1.0× 35 351

Countries citing papers authored by David Ambrož

Since Specialization
Citations

This map shows the geographic impact of David Ambrož's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ambrož with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ambrož more than expected).

Fields of papers citing papers by David Ambrož

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ambrož. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ambrož. The network helps show where David Ambrož may publish in the future.

Co-authorship network of co-authors of David Ambrož

This figure shows the co-authorship network connecting the top 25 collaborators of David Ambrož. A scholar is included among the top collaborators of David Ambrož based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Ambrož. David Ambrož is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Havránek, Štěpán, et al.. (2024). Benefits from catheter ablation in patients with pulmonary hypertension: Recent advances. Kardiologia Polska. 82(6). 602–608. 1 indexed citations
2.
Havránek, Štěpán, Tomáš Skála, Pavel Jansa, et al.. (2023). Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study. EP Europace. 25(5). 5 indexed citations
3.
4.
5.
Procházka, Pavel, et al.. (2023). Endovascular treatment of pelvic congestion syndrome. 22(2). 79–82.
6.
Jansa, Pavel, David Ambrož, Michael Aschermann, et al.. (2022). Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension. Journal of Clinical Medicine. 11(20). 6189–6189. 1 indexed citations
7.
8.
Ambrož, David, Pavel Jansa, Jaroslav Lindner, et al.. (2021). The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension. PLoS ONE. 16(1). e0245752–e0245752. 21 indexed citations
9.
Ambrož, David, Pavel Jansa, Jan Bělohlávek, et al.. (2020). Predictors of survival in patients with pulmonary hypertension and acute right heart failure. Bratislavské lekárske listy/Bratislava medical journal. 121(3). 230–235. 7 indexed citations
10.
Dytrych, Vladimír, David Ambrož, Jan Kunstýř, et al.. (2020). Long-term experience with implantable treprostinil pumps in pulmonary arterial hypertension. Bratislavské lekárske listy/Bratislava medical journal. 121(5). 356–361. 2 indexed citations
11.
Ambrož, David, et al.. (2019). Surgical treatment of chronic thromboembolic pulmonary hypertension. Vnitřní lékařství. 65(5). 353–358. 3 indexed citations
12.
Havránek, Štěpán, et al.. (2019). The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension. BMC Cardiovascular Disorders. 19(1). 157–157. 9 indexed citations
13.
Kuchynka, Petr, Josef Marek, Lukáš Lambert, et al.. (2016). Utility of cardiac CT for evaluating delayed contrast enhancement in dilated cardiomyopathy. Herz. 42(8). 776–780. 6 indexed citations
14.
Jansa, Pavel, David Ambrož, & Jaroslav Lindner. (2014). [Past and present issues of the pulmonary circulation in the General University Hospital in Prague].. PubMed. 60(12). 1051–4.
15.
Jansa, Pavel, Jiří Jarkovský, Hikmet Al‐Hiti, et al.. (2014). Epidemiology and long-term survival of pulmonary arterial hypertension in the Czech Republic: a retrospective analysis of a nationwide registry. BMC Pulmonary Medicine. 14(1). 45–45. 53 indexed citations
16.
Kalousová, Marta, Vilém Danzig, Magdaléna Hodková, et al.. (2013). Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease – a prospective observational study. BMC Nephrology. 14(1). 142–142. 12 indexed citations
17.
Jansa, Pavel, Radim Bečvář, David Ambrož, et al.. (2011). Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic. Clinical Rheumatology. 31(3). 557–561. 11 indexed citations
18.
Paleček, Tomáš, Pavel Jansa, David Ambrož, et al.. (2010). Are pulmonary artery pulsatility indexes able to differentiate chronic pulmonary thromboembolism from pulmonary arterial hypertension? An echocardiographic and catheterization study. Heart and Vessels. 26(2). 176–182. 4 indexed citations
19.
Kunstýř, Jan, A. A. Klein, Jaroslav Lindner, et al.. (2008). Use of High-Thoracic Epidural Analgesia in Pulmonary Endarterectomy: A Randomized Feasibility Study. The Heart Surgery Forum. 11(4). E202–E208. 5 indexed citations
20.
Lindner, Jaroslav, Pavel Jansa, Jan Kunstýř, et al.. (2006). Implementation of a New Programme for the Surgical Treatment of CTEPH in the Czech Republic - Pulmonary Endarterectomy. The Thoracic and Cardiovascular Surgeon. 54(8). 528–531. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doug Helmersen Breakdown of academic impact, for papers by Katsumasa Miyaji Breakdown of academic impact, for papers by Marcin Waligóra Breakdown of academic impact, for papers by Jaroslaw Dudczak Breakdown of academic impact, for papers by J. Deague Breakdown of academic impact, for papers by F. Leroy Ladurie Breakdown of academic impact, for papers by J Suntharalingam Breakdown of academic impact, for papers by S Cabrol Breakdown of academic impact, for papers by Panagiota Xanthouli Breakdown of academic impact, for papers by Hiroto Shimokawahara
Rankless by CCL
2026